Articles with public access mandates - Paul GallagherLearn more
Not available anywhere: 7
The impact of a structured pharmacist intervention on the appropriateness of prescribing in older hospitalized patients
D O’Sullivan, D O’Mahony, MN O’Connor, P Gallagher, S Cullinan, ...
Drugs & aging 31, 471-481, 2014
Mandates: Health Research Board, Ireland
Deprescribing in older people approaching end-of-life: development and validation of STOPPFrail version 2
D Curtin, P Gallagher, D O’Mahony
Age and ageing 50 (2), 465-471, 2021
Mandates: European Commission
Prevention of adverse drug reactions in hospitalised older patients using a software-supported structured pharmacist intervention: a cluster randomised controlled trial
D O’Sullivan, D O’Mahony, MN O’Connor, P Gallagher, J Gallagher, ...
Drugs & aging 33, 63-73, 2016
Mandates: Health Research Board, Ireland
Deprescribing in older people approaching end of life: a randomized controlled trial using STOPPFrail criteria
D Curtin, E Jennings, R Daunt, S Curtin, M Randles, P Gallagher, ...
Journal of the American Geriatrics Society 68 (4), 762-769, 2020
Mandates: European Commission
The adverse drug reaction risk in older persons (ADRROP) prediction scale: derivation and prospective validation of an ADR risk assessment tool in older multi-morbid patients
D O’Mahony, MN O’Connor, J Eustace, S Byrne, M Petrovic, P Gallagher
European Geriatric Medicine 9, 191-199, 2018
Mandates: Health Research Board, Ireland
STOPPFrail (Screening Tool of Older Persons’ Prescriptions in Frail adults with a limited life expectancy) criteria: application to a representative population awaiting long …
AH Lavan, D O’Mahony, P Gallagher
European journal of clinical pharmacology 75, 723-731, 2019
Mandates: Health Research Board, Ireland
Adverse Drug Events Due to Potentially Inappropriate Medications—Reply
D O’Mahony, HJ Hamilton, PF Gallagher, C Ryan, S Byrne
Archives of Internal Medicine 171 (21), 1960-1961, 2011
Mandates: US National Institutes of Health
Available somewhere: 15
Dementia prevention, intervention, and care
G Livingston, A Sommerlad, V Orgeta, SG Costafreda, J Huntley, D Ames, ...
The lancet 390 (10113), 2673-2734, 2017
Mandates: Alzheimers's UK, UK Economic and Social Research Council, UK Medical …
STOPP/START criteria for potentially inappropriate prescribing in older people: version 2
D O'Mahony, D O'Sullivan, S Byrne, MN O'Connor, C Ryan, P Gallagher
Age and ageing 44 (2), 213-218, 2014
Mandates: Health Research Board, Ireland
Prevention of hospital‐acquired adverse drug reactions in older people using screening tool of older persons' prescriptions and screening tool to alert to right treatment …
MN O'Connor, D O'Sullivan, PF Gallagher, J Eustace, S Byrne, ...
Journal of the American Geriatrics Society 64 (8), 1558-1566, 2016
Mandates: Health Research Board, Ireland, European Commission
Doctors' perspectives on the barriers to appropriate prescribing in older hospitalized patients: a qualitative study
S Cullinan, A Fleming, D O'Mahony, C Ryan, D O'Sullivan, P Gallagher, ...
British journal of clinical pharmacology 79 (5), 860-869, 2015
Mandates: Health Research Board, Ireland
In-hospital adverse drug reactions in older adults; prevalence, presentation and associated drugs—a systematic review and meta-analysis
ELM Jennings, KD Murphy, P Gallagher, D O’Mahony
Age and ageing 49 (6), 948-958, 2020
Mandates: Health Research Board, Ireland, European Commission
Comparing approaches to optimize cut-off scores for short cognitive screening instruments in mild cognitive impairment and dementia
R O’Caoimh, Y Gao, A Svendovski, P Gallagher, J Eustace, DW Molloy
Journal of Alzheimer's Disease 57 (1), 123-133, 2017
Mandates: Canadian Institutes of Health Research
Prevalence, management, and outcomes of SARS-CoV-2 infections in older people and those with dementia in mental health wards in London, UK: a retrospective observational study
G Livingston, H Rostamipour, P Gallagher, C Kalafatis, A Shastri, ...
The Lancet Psychiatry 7 (12), 1054-1063, 2020
Mandates: UK Medical Research Council, National Institute for Health Research, UK …
Adverse drug reactions in an oncological population: prevalence, predictability, and preventability
AH Lavan, D O'Mahony, M Buckley, D O'Mahony, P Gallagher
The oncologist 24 (9), e968-e977, 2019
Mandates: Health Research Board, Ireland
Incident adverse drug reactions in geriatric inpatients: a multicentred observational study
A Lavan, J Eustace, D Dahly, E Flanagan, P Gallagher, S Cullinane, ...
Therapeutic Advances in Drug Safety 9 (1), 13-23, 2018
Mandates: Health Research Board, Ireland, European Commission
Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases
D Curtin, T Dukelow, K James, D O’Donnell, D O’Mahony, P Gallagher
European journal of clinical pharmacology 75, 427-432, 2019
Mandates: European Commission
The effect of SENATOR (Software ENgine for the Assessment and optimisation of drug and non-drug Therapy in Older peRsons) on incident adverse drug reactions (ADRs) in an older …
AH Lavan, D O’Mahony, P Gallagher, R Fordham, E Flanagan, D Dahly, ...
BMC geriatrics 19, 1-12, 2019
Mandates: Health Research Board, Ireland
Predicting 1‐year mortality in older hospitalized patients: External validation of the HOMR model
D Curtin, DL Dahly, M van Smeden, DP O'Donnell, D Doyle, P Gallagher, ...
Journal of the American Geriatrics Society 67 (7), 1478-1483, 2019
Mandates: European Commission
Medication-related quality of life (MRQoL) in ambulatory older adults with multi-morbidity and polypharmacy
ELM Jennings, D O’Mahony, PF Gallagher
European Geriatric Medicine, 1-5, 2022
Mandates: European Commission
Publication and funding information is determined automatically by a computer program